TUE, 2 JUN 2026 · EDITION 84 · BASE L2
High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
New Scientist · article
People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions
View source →https://www.newscientist.com/article/2528738-transformative-pancreatic-cancer-drug-doubles-survival-time/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=homeHash 0xa71f8a6199977f3d33b21ae1de30d541b3ed359bcf622070a6413bb18c158724
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.